Department of Medicinal Chemistry, School of Pharmacy, Health Science Center, Xi'an Jiaotong University, No 76, Yanta West Road, Xi'an 710061, PR China.
Jiangsu Simcere Pharmaceutical Co. Ltd., No 699-18, Xuan Wu District, Nanjing 210042, PR China.
Bioorg Med Chem. 2018 Oct 1;26(18):5029-5036. doi: 10.1016/j.bmc.2018.08.037. Epub 2018 Aug 31.
A series of novel hedgehog signaling pathway inhibitors have been designed and synthesized based on our previously reported scaffold of 4-(2-pyrimidinylamino)benzamide. The Hh signaling pathway inhibitory activities were evaluated by Gli-luciferase reporter method and most compounds showed more potent inhibitory activities than vismodegib. Three compounds were picked out to evaluated in vivo for their PK properties, and compound 23b bearing a 2-pyridyl A-ring and (morpholin-4-yl)methylene at 3-position of D-ring demonstrated satisfactory PK properties. This study suggested the 4-(2-pyrimidinylamino)benzamides were a series of potent Hh signaling pathway inhibitors, deserving to further structural optimization.
基于我们之前报道的 4-(2-嘧啶基氨基)苯甲酰胺骨架,设计并合成了一系列新型 hedgehog 信号通路抑制剂。通过 Gli-荧光素酶报告基因法评估了 Hh 信号通路抑制活性,大多数化合物的抑制活性均强于 vismodegib。选择了三个化合物进行体内 PK 特性评价,其中带有 2-吡啶基 A 环和 D 环 3 位的 (吗啉-4-基)亚甲基的化合物 23b 表现出令人满意的 PK 特性。本研究表明 4-(2-嘧啶基氨基)苯甲酰胺是一系列有效的 Hedgehog 信号通路抑制剂,值得进一步的结构优化。